Review




Structured Review

Stempeutics stempeucel's allogeneic bm-mscs product
MSC-based clinical trials for nerve injury and spinal cord injury (SCI).
Stempeucel's Allogeneic Bm Mscs Product, supplied by Stempeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stempeucel's allogeneic bm-mscs product/product/Stempeutics
Average 90 stars, based on 1 article reviews
stempeucel's allogeneic bm-mscs product - by Bioz Stars, 2026-02
90/100 stars

Images

1) Product Images from "Beyond conventional therapies: MSCs in the battle against nerve injury"

Article Title: Beyond conventional therapies: MSCs in the battle against nerve injury

Journal: Regenerative Therapy

doi: 10.1016/j.reth.2024.12.017

MSC-based clinical trials for nerve injury and spinal cord injury (SCI).
Figure Legend Snippet: MSC-based clinical trials for nerve injury and spinal cord injury (SCI).

Techniques Used: Clinical Proteomics, Transplantation Assay, Derivative Assay, Diffusion-based Assay, Imaging, Membrane, Cell Culture, Injection



Similar Products

90
Stempeutics stempeucel's allogeneic bm-mscs product
MSC-based clinical trials for nerve injury and spinal cord injury (SCI).
Stempeucel's Allogeneic Bm Mscs Product, supplied by Stempeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stempeucel's allogeneic bm-mscs product/product/Stempeutics
Average 90 stars, based on 1 article reviews
stempeucel's allogeneic bm-mscs product - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


MSC-based clinical trials for nerve injury and spinal cord injury (SCI).

Journal: Regenerative Therapy

Article Title: Beyond conventional therapies: MSCs in the battle against nerve injury

doi: 10.1016/j.reth.2024.12.017

Figure Lengend Snippet: MSC-based clinical trials for nerve injury and spinal cord injury (SCI).

Article Snippet: An Indian company known as Stempeutics conducted a phase 4 clinical trial in September 2021, and the results indicated that Stempeucel's allogeneic BM-MSCs product was safe, effective, and had positive, long-lasting effects that not only reduced pain but aided in ulcer healing for severe limb ischemia triggered by Buerger's disease.

Techniques: Clinical Proteomics, Transplantation Assay, Derivative Assay, Diffusion-based Assay, Imaging, Membrane, Cell Culture, Injection